title: Minimal residual disease monitoring in multiple myeloma: flow cytometry is the method of choice.
authors.forename: Roger G
authors.initials: RG
authors.lastname: Owen
authors.forename: Andy C
authors.initials: AC
authors.lastname: Rawstron
mesh_terms: D005434:Flow Cytometry; D006801:Humans; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000601:surgery; D018365:Neoplasm, Residual / Q000175:diagnosis*; D033581:Stem Cell Transplantation